Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

ASYSTEM Partners with Warner Bros. Discovery Global Consumer Products on New Supplements


ASYSTEM launches exciting new partnership, creating Bruce Wayne inspired pre-workout and immunity supplements.

Science forward supplements brand ASYSTEM today released PRE-WORKOUT+, a Bruce Wayne inspired supplement that provides explosive energy so you can run faster, lift more, swim further, hit harder. PRE-WORKOUT+ is the first of two ASYSTEM products under Warner Bros. Discovery Global Consumer Products’ (WBDGCP) new lifestyle label, Wayne Enterprises and is available now exclusively on ASYSTEM.com and Uncrate.com®. IMMUNITY+ a high potency immune support supplement engineered to protect you from illness, help you recover quicker and feel your best – everyday, launches on November 2nd.

ASYSTEM joins other high-performance brands to release new products under Wayne Enterprises. Launched in Fall 2022, ‘Wayne Enterprises’ is a sophisticated lifestyle label inspired by DC’s Bruce Wayne. The elevated collection, developed in partnership with Uncrate, takes its cues from Bruce Wayne’s elegant and sophisticated taste and across numerous categories including high-end designer fashion, accessories, health/fitness, personal care, electronics, houseware and more.

“Rarely does a collaboration excite us as much as this one, so we are honored to be a part of the Wayne Enterprises Collection in partnership with Warner Bros. Discovery, DC and Uncrate.com,” said Oli Walsh, ASYSTEM’s CEO and Founder. “Our revolutionary PRE-WORKOUT+ and IMMUNITY+ supplements has been created to transform your exercise regime and activate your immune system, so we knew it needed to combine cutting edge science with technical style to match Bruce Wayne’s taste for the finer things in life.”

The limited edition PRE-WORKOUT+ supplement is available for $45 on ASYSTEM.com and Uncrate.com while supplies last. It’s powered by 250 mg of the potent fungus, Cordyceps mushrooms, known as ‘Himalayan Gold’, as well as 400 mg of Ashwaganhda and Beetroot Powder, which have been shown to boost energy and improve muscle strength and endurance. The natural tea leaves used in clinically-backed InnovaTea® are proven to help trigger a range of performance-specific benefits including improved focus, faster reaction time, and increased endurance. The formula contains natural caffeine and zero sugar to ensure clean energy with no crash.

Launching next week, the IMMUNITY+ supplement is available for $45 on ASYSTEM.com and Uncrate.com while supplies last. The unique formulation is anchored by the key clinically-backed ingredient, ElderMune™. Highly innovative, it is shown to help activate your immune response, boost your capacity to fight off infections, and reduce the duration and severity of respiratory illnesses. This is combined with Sunfiber®, a prebiotic fiber that supports the healthy flora in the gut where 70% of your immune system can be found. The benefits of IMMUNITY+ also come from the combining 450 mg of two powerful mushrooms, Chaga and Agarikon, known as ‘the elixir of long life’. These mushrooms have been used for centuries to boost immunity with their high concentration of antioxidants making them amongst the most powerful medicinal mushrooms known to us.

Both products are climate positive and launch with a zero plastic, infinitely recyclable container. By partnering with Sea Trees to regenerate coastal ecosystems, each ASYSTEM product removes more CO2 than it emits.

PRE-WORKOUT+ and IMMUNITY+ were created by ASYSTEM LABS, a product incubation studio that partners with forward-thinking consumer brands to unlock the huge potential of expansion into the supplements, vitamins and nutritional products category.

####

About ASYSTEM

LA-based ASYSTEM is on a mission to make the benefits of clinical science accessible to all by creating science-forward supplements for all your health needs & goals. Their current assortment spans Pain Relief, Anti-Anxiety, Sleep, Productivity, Libido & Men’s Health, with products available on ASYSTEM.com and at prestigious retailers such as Nordstrom, Bergdorf Goodman & Saks Fifth Ave.

About ASYSTEM LABS

ASYSTEM LABS is a product incubation studio that partners with forward-thinking consumer brands to unlock the huge potential of expansion into the supplements, vitamins and nutritional products category. Visit ASYSTEMLABS.com for more information.

Warner Bros. Discovery Global Consumer Products (WBDGCP), part of Warner Bros. Discovery Global Brands and Experiences, extends the company’s powerful portfolio of entertainment brands and franchises into the lives of fans around the world. WBDGCP partners with best-in-class licensees globally on award-winning toy, fashion, home décor and publishing programs inspired by the biggest franchises from Warner Bros.’ film, television, animation, and games studios, HBO, Discovery, DC, Cartoon Network, HGTV, Eurosport, Adult Swim, and more. With innovative global licensing and merchandising programs, retail initiatives, and promotional partnerships, WBDGCP is one of the leading licensing and retail merchandising organizations in the world.

DC, part of Warner Bros. Discovery, creates iconic characters and enduring stories and is one of the world’s largest publishers of comics and graphic novels. DC’s creative work entertains audiences of every generation around the world with DC’s stories and characters integrated across Warner Bros. Discovery’s film, television, animation, consumer products, home entertainment, games, and themed experiences divisions, and on the DC Universe Infinite digital comic subscription service. Learn more at DC.com.

About Uncrate

Uncrate is the leading buyer’s guide for men. With tens of thousands of products and places covered and more than 1.5 million monthly readers, Uncrate is widely known for digging up the best of the best men’s products. With new gear posted every weekday, Uncrate has quickly become one of the largest men’s publications, both online and in print, with over 10 million page views each month. Since 2005, Uncrate’s dedicated readers have visited multiple times per day to find out about the latest stuff for guys and the people who purchase for them. Uncrate’s insightful and daily updates, with near real-time coverage of new product launches, has gained the site an audience of discerning men who turn to Uncrate for the next great thing.

New Evidence Suggests That “Perfect” Woman You Follow on Social Media is Burning You Out


A new study of more than 4,200 women, conducted by TrueveLab in collaboration with The University of Tennessee Department of Industrial Organizational Psychology, analyzed the impact of social media and its unique influence on this generation of women. Burnout Study in Women found that time spent on social media was not the biggest predictor of burnout, but how women feel after comparing themselves to others while using social media.

In fact, more than 60% of women said they compare themselves against a woman who seems to do it all. Not only were participants more likely to feel negatively about themselves after social media, these negative feelings were also directly linked with burnout – more so than time spent using social media. The most common emotions triggered by social media self-comparisons were envy (53%) and worry (36%).

“It’s not just that we have more to do – and more ‘ideal’ to try to hit – we also have SO MANY more ways to compare ourselves to others than ever before,” says Dr. Darria Long, founder of Trueve Lab and study co-author. “By default, we’re measured against some fictional ‘do it all’ avatar, and social media algorithms particularly trigger this, leading to what I call ‘Comparitonitis’. Plus, if you’re not doing it perfectly, then it’s now labeled as a #fail,” adds Dr. Long.

The study also coined the term, The Do it All Discrepancy, the difference between how much a woman feels she is expected to do versus what she feels she actually can do. This reflects the very real expansion of women’s responsibilities, plus the idealized “do it all” expectations that have risen over the past generation. Alarmingly, the Burnout Study in Women showed that 82% of women felt that they should be able to do it all, but only 7% felt they could.

Most study respondents (87%) felt they never had enough time to get everything done, and that they felt fully present at home or work only 53% of the time. “Women are starved for time and focus,” says Dr. Long. “That’s explained in our results by the Do It All Discrepancy experienced by so many women. We now face the greater real obligations – – such as work, childcare, parenting, home management – – plus the ideal expectations we carry to ‘do it all,’ from travel sports at age three to home-baked organic cakes – all with perfect highlighted hair.”

Study authors noted that solutions for burnout require changes both on a systematic and corporate level, as well as those that can be impactful on an individual level. Future publications will dive even further into each of those.

To help women improve burnout now, study authors developed the What’s Your Burnout Risk (and what to do about it) Quiz, to give women data-driven solutions to burnout that they can enlist now.

These findings, the first published in the ongoing Burnout Study in Women, and a series of planned publications, are titled, “Understudied social influences on general and parental burnout: Social media-related emotions, comparisons, and the do it all discrepancy” and published by Frontiers in Psychology. This study was conducted by TrueveLab, funded by LUNA Bar and Computers4Kidz, and in media partnership with Good Housekeeping.

About The Burnout Study in Women: This publication was based on an academic survey by TrueveLab and the University of Tennessee Department of Industrial Organizational Psychology completed between October and December 2021. The Burnout Study in Women study was launched to establish a more holistic understanding of burnout as it develops from the many life domains experienced (and juggled) by women, and how these multiple and complex spheres of life interact for burnout. This ongoing study will release future publications, aimed at developing targeted solutions for burnout in women.

About Trueve: Founded by Dr. Darria Long, Trueve takes a data-driven lens to women’s health and parenting. Trueve believes that every woman deserves access to evidence-based health information, and the peace of mind that comes with that. TrueveLab is the research arm of Trueve, performing original research in areas of women’s health and parenting, where data is deficient.

About Darria Long, MD MBA: Dr. Darria is a board-certified Harvard and Yale-trained emergency physician and Clinical Assistant Professor at the University of Tennessee. She is a regular guest on national news networks, mom of two, author of national bestselling Mom Hacks, and TedX speaker of An End to “Crazy Busy”.

About the UTC Research Team: Dr. Chris Cunningham and Dr. Kristen Black are faculty members at The University of Tennessee Department of Industrial Organizational Psychology. Combined, they have more than 30 years of experience in research, teaching, and practical intervention work related to the protection and promotion of worker health, safety, and well-being. They are authors of, Essentials of Occupational Health Psychology, focused on practical guidance for worker health through targeting psychological stress at work, workplace safety, interpersonal stress, recovery from demands, and work-family dynamics.

Share article on social media or email:

NutraScience Labs Receives Its Renewed cGMP Certification


News Image

“Our high NSF score shows our entire team’s continued commitment to offering the highest level of quality control for our customers and their products every day,” said Vincent Tricarico, Executive Vice President and Chief Operating Officer at NutraScience Labs.

NutraScience Labs, a leading provider of dietary supplement manufacturing services, today announced the company has successfully completed and passed the National Sanitation Foundation’s (NSF) stringent auditing process, renewing the company’s Current Good Manufacturing Practices (cGMP) certification. The audit ensures that its facilities comply with FDA Code 21CFR111 for dietary supplements and follow NSF guidelines for all aspects of storage and distribution.

The annual certification process entailed a live audit of NutraScience Labs’ two facilities in Farmingdale and Hauppauge, where an NSF auditor inspected the facility, personnel, standard operating procedures and business practices, and other aspects of the business. The Farmingdale location has been cGMP Certified for over 10 years, while the Hauppauge facility earned its certification earlier this year.

“Our high NSF score shows our entire team’s continued commitment to offering the highest level of quality control for our customers and their products every day,” said Vincent Tricarico, Executive Vice President and Chief Operating Officer at NutraScience Labs.

Some of the features at NutraScience Labs facilities that showcase the company’s exemplary standards include:

  • Unlike warehouse facilities sometimes utilized by big box retailers and online marketplaces, NutraScience Labs’ two facilities are climate-controlled to ensure the quality and stability of the supplements stored.
  • Solar energy and gas to operate on an efficient carbon footprint.
  • State-of-the-art inventory and picking system using iPads and barcode authentication.
  • Special racking systems to maximize storage space and allow quicker turnaround time for prepping and shipping.

“Our facility is truly a best-in-class operation,” said Gene Bruno, Vice President of Scientific and Regulatory Affairs at NutraScience Labs. “The renewed certification is considered the gold standard in the industry and solidifies our company’s credibility and integrity regarding good manufacturing practices.”

NutraScience Labs provides dietary supplement brands with best-in-class dietary supplement manufacturing services and offers in-house packaging, label design, and fulfillment services. The company’s headquarters is located at 70 Carolyn Boulevard in Farmingdale, and its distribution facility is at 901 Motor Parkway in Hauppauge.

About NutraScience Labs

NutraScience Labs is headquartered in New York and provides dietary supplement brands with best-in-class contract supplement manufacturing services and offers in-house packaging, label design, and fulfillment services. The team at NutraScience Labs possesses over 120 years of industry experience and have successfully contract manufactured high-quality dietary supplements for over 2,300 brands located in the United States and around the globe. For more information about the company and its services, visit NutraScienceLabs.com.

Share article on social media or email:

New research from Shady Grove Fertility (SGF) can help provide an optimal age for egg donors and those pursuing elective egg freezing


New research from Shady Grove Fertility (SGF) can help provide an optimal age for egg donors and those pursuing elective egg freezing.

“At SGF, we pride ourselves in providing evidence-based fertility care; therefore, our research team conducted a study to help guide intended parents who are growing their family through egg donation.”

New research from Shady Grove Fertility (SGF) conducted with Donor Egg Bank USA offers reassurance for intended parents growing their family with the use of an egg donor and can offer guidance to patients pursuing elective egg freezing.

“Egg donation helps fulfill the dreams of parenthood for individuals and couples faced with infertility,” shares Phillip A. Romanski, M.D., M.Sc., SGF physician. “At SGF, we pride ourselves in providing evidence-based fertility care; therefore, our research team conducted a study to help guide intended parents who are growing their family through egg donation.”

The findings of SGF and Donor Egg Bank USA’s study reassure patients using eggs from donors ages 21 through 32 yielded a similar ongoing pregnancy rate.

“We decided to conduct this study because some data have suggested an increase in chromosomal errors among the youngest infertility patients,” adds Dr. Romanski. “Thankfully, we didn’t find cause for significant concern among recipients of eggs from younger donors.”

The study found that the pregnancy outcomes for each year of donor ages between 21 and 32 were comparable to donor eggs age 29.

The retrospective cohort study was conducted by SGF physicians Phillip A. Romanski, M.D., M.Sc., and Kate Devine, M.D., and Melissa Stratton B.A. and Wayne Caswell M.S. from Donor Egg Bank USA. The SGF research team looked at egg donor recipient cycles at Donor Egg Bank USA between 2013 and 2021. In total, the study looked at 3,678 donor egg cycles.

Dr. Romanski joins the SGF New York physician team this fall and provides patient care at SGF’s Manhattan location. In spring 2023, Dr. Romanski will open SGF New York’s SoHo location. He is board certified in Obstetrics and Gynecology and board eligible in Reproductive Endocrinology and Infertility. He specializes in third-party reproduction and egg freezing as well as diminished ovarian reserve, premature ovarian failure, and reproductive surgery. He serves as the Director of Research for SGF New York. At this year’s ASRM national meeting, he will receive the “Star Reviewer” award from Fertility and Sterility for his exemplary service to the journal, and his research will also be awarded the “First Prize Video Research Award” by ASRM.

SGF is one of only a few private practice fertility centers in the country to employ a full-time dedicated research team, which operates under Director of Research, Kate Devine, M.D., a board certified reproductive endocrinologist who sees patients at SGF’s Washington, D.C., K Street location. Dr. Devine also serves as the Executive Medical Director and Chief Research Officer at US Fertility, the largest network of physician-owned and physician-led fertility practices in the United States, of which SGF is a founding partner practice.

As a premier IVF and fertility center of excellence, SGF continues to make a sustained commitment to clinical research and educating physicians in training.

To learn more about ongoing research being conducted at SGF, visit http://www.shadygrovefertility.com/research.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 50 locations, including the newest location in Raleigh, North Carolina, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Share article on social media or email:

SmartTRAK Expands Leadership Team to Drive Medtech Insights Platform Strategic Growth


SmartTRAK Logo

“Having both Linda and Joe on the leadership team aligns with our client expansion and investment in our ‘Insights-as-a-Service’ capabilities. It’s an exciting time for SmartTRAK as we roll out our Enterprise offering, new market tools and data insights solutions.” – Sharon O’Reilly, SmartTRAK CEO

SmartTRAK, the leading global Medtech business and market insights solution in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, announces the hiring of Linda Bernier as Chief Growth Officer and the promotion of Joe Mish to Vice President of Sales. Both executives bring healthcare technology and data analytics expertise to influence SmartTRAK’s product direction and enterprise growth strategies.

“Having both Linda and Joe on the leadership team aligns with our client expansion objectives and investment in our ‘Insights-as-a-Service’ capabilities,” says CEO Sharon O’Reilly. “It’s an exciting time for SmartTRAK as we roll out our Enterprise offering and collaborate with customers to develop new market tools and data insights solutions. Linda brings 20+ years of experience in new business development and voice of client to drive technology innovation. Joe spent a decade in medical device sales at Stryker and Zimmer Biomet as well as selling enterprise data analytics and SaaS solutions. Combined, they are a powerful team with strong industry and client focus that will take the company to the next level.”

As Chief Growth Officer, Linda Bernier is responsible for sales, marketing and customer success. She was most recently Chief Marketing Officer for high growth SaaS and tech-enabled service companies spanning multiple healthcare markets. “I’ve spent my career helping CEOs execute their strategic vision. I’m looking forward to working with Sharon and the SmartTRAK team to achieve the company’s full potential as the leading market insights solution in the Medtech industry. We are focusing on customer needs and engagement to uncover new ways we can deliver value through tools, as well as expand our insights so clients can be more efficient while accelerating their innovations.”

Joe Mish most recently served as Area VP for SmartTRAK before his promotion to VP of Sales. He will lead the commercial sales team as well as the SmartTRAK Enterprise roll out, which provides customers with company-wide access to the platform, customization, integration to other systems and increased automation. “I am thrilled to be part of a team with exceptional people, a great culture and a crucial mission to provide meaningful insights to the Medtech industry. What motivates me each day is hearing how SmartTRAK is our customers’ trusted source for market insights, and how they heavily rely on the platform and our expert analysts to make strategic decisions about their business. That makes our relationship with customers more of a partnership, rather than just a client and vendor.”

About SmartTRAK

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. Our propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK Enterprise platform includes SmartTRAK Daily Updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product, and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. For more information visit http://www.SmartTRAK.com and follow us on LinkedIn.

Share article on social media or email:

GeBBS Named as “Leader” in Everest Group Medical Coding Operations PEAK Matrix® Assessment 2023


We are honored to be named as Leader in Everest Group’s PEAK Matrix

GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company), a leading provider of Revenue Cycle Management (RCM) Solutions for Healthcare Providers and Payers, announced that it has been named as a Leader in Medical Coding Operations by Everest Group. GeBBS was recognized in the top quartile for performance in market success and capability advancement as part of Everest Group’s Medical Coding Operations PEAK Matrix® Assessment 2023.

The report evaluated 22 operations service providers based on market impact, vision, and the ability to deliver services successfully-as defined by subdimensions including market adoption, portfolio mix, value delivered, and strategic vision-to identify each organization’s overall market leadership position, labeled as Aspirant, Major Contender, or Leader. GeBBS has been named “Leader” for its significant growth and market success.

Medical coding is one of the most outsourced segments in the Revenue Cycle Management (RCM) value chain. GeBBS’ NLP powered iCode platform complimented with one of the largest pools of certified and highly trained coding experts in the industry focuses on enhanced accuracy, compliance, denial prevention, and accurate reimbursement to optimize performance with results driven outcomes.

“We are honored to be named as Leader in Everest Group’s PEAK Matrix,” said Milind Godbole, CEO & Managing Director of GeBBS Healthcare Solutions. “Our leadership position in this assessment validates our long-standing vision and market differentiation in exceeding client expectations while helping them achieve new levels of success.”

The Everest Group PEAK Matrix is a proprietary framework for assessing the relative market success and overall capability of service providers based on Performance, Experiences, Ability, and Knowledge. Each service provider is comparatively assessed in two dimensions: market success and delivery capabilities. Market success is measured by revenue, number of clients and year-over-year growth. Delivery capability is measured by the scale of operations, scope, technology and innovation, delivery footprint and buyer satisfaction. The resulting matrix categorizes service providers as Leaders, Major Contenders, and Aspirants.

About GeBBS

GeBBS Healthcare Solutions is a KLAS rated leading provider of Revenue Cycle Management (RCM) services and Risk Adjustment solutions. GeBBS’ innovative technology, combined with over 12000+ strong global workforce, helps clients improve financial performance, adhere to compliance, and enhance the patient experience. Headquartered in Los Angeles, CA, GeBBS has won numerous accolades for its medical coding outsourcing and medical billing outsourcing, including being ranked in Modern Healthcare’s Top 20 Largest RCM Firms, Black Book Market Research’s Top 20 RCM Outsourcing Services, and Inc. 5000’s fastest growing private companies in the U.S. For more information, please visit our website.

About Everest Group

Everest Group is a consulting and research firm focused on strategic IT, business services, engineering services, and sourcing. Our clients include leading global enterprises, service providers, and investors. Through our research-informed insights and deep experience, we guide clients in their journeys to achieve heightened operational and financial performance, accelerated value delivery, and high-impact business outcomes. Details and in-depth content are available at http://www.everestgrp.com/.

For more information contact:

Tyler Cowart

310-953-4444 ext. 214

tyler.cowart@gebbs.com

Share article on social media or email:

Study Leveraging DEARhealth Care Management Platform for Ovarian Cancer Care Launched


GSK is pleased to provide funding to support the UC Cancer Consortium, leveraging DEARhealth’s innovative technology, as part of our Patient Empowerment Alliance,” said Shannon Altimari, Global Head of Oncology Advocacy to Outcomes, GSK.

DEARhealth Inc., a health tech company focused on patients with a chronic condition and their continuous care management, announced today the launch of a randomized, multi-center, controlled study to assess the efficacy of DEARhealth’s risk-based care management platform in improving the health of women with ovarian cancer.

The study “Value-Based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)” will be led by the University of California (UC) Cancer Consortium, a collaboration of UC’s five National Cancer Institute-designated Comprehensive Cancer Centers. The study is part of the GSK supported studies program and the company’s Patient Empowerment Alliance (P.E.A.), an innovative program created to help test, measure, and validate tools that show potential to empower patients as core members of their oncology care team with the goal of improving care outcomes.

Gynecologic oncologists at each UC Cancer Center will direct the study, which follows a successful feasibility study at UCLA Jonsson Comprehensive Cancer Center, which was led by Joshua G. Cohen, MD, a gynecologic oncologist formerly at the David Geffen School of Medicine at UCLA. Dr. Tiffany Lai, Assistant Professor in gynecologic oncology at UCLA will serve as the Principal Investigator. Co-Principal Investigators at each UC Cancer Center includes Drs. Lee-May Chen (UCSF), Pratibha Binder (UCSD), Jill Tseng (UCI), Hui (Amy) Chen and Rebecca Brooks (UC Davis), and Cortney Eakin (UCLA).

“We’re excited to embark on this important study that we hope will show the benefits of a harmonized care pathway for ovarian cancer accessible through the DEARhealth care management platform,” said Dr. Daniel Hommes, MD, PhD, and Co-founder of DEARhealth.

“GSK is pleased to provide funding to support the UC Cancer Consortium, leveraging DEARhealth’s innovative technology, as part of our Patient Empowerment Alliance,” said Shannon Altimari, Global Head of Oncology Advocacy to Outcomes, GSK. “The P.E.A. is a novel component of our supported studies program that applies scientific rigor to the assessment of technologies, platforms, and interventions, which may have a positive impact on patient engagement and outcomes.”

DEARhealth’s care management platform offers risk-based care pathway recommendation functionality with the input of data from electronic medical record (EMR) systems, to support provider teams, patients, and their caregivers in the management of chronic conditions. Recommendations are focused on the Triple Aim: enhancing experiences, improving outcomes, and managing costs. The DEARhealth platform uses clinical data and continuously captured patient-reported outcome measures (PROMs), including those related to disease progression, medications, and mental health, to assess patients and deliver recommendations to adjust the treatment to new developments in a patient’s health status. The study aims to deliver evidence-based care recommendations to providers and patients in real-time.

Participants in the study will need to opt-in to data sharing from their UC electronic medical record as part of consent for the trial. All patient data will be securely encrypted for patient privacy.

###

About DEARhealth

DEARhealth is a health tech company founded in 2013, by senior University of California, Los Angeles (UCLA) medical experts to transform healthcare by using risk-based care pathways for chronic disease care management. DEARhealth is a validated, software as a medical device, whose partners include health systems, providers, payers, and pharmaceutical companies globally. Investors in DEARhealth include Philips Health Technology Ventures, Vesalius Biocapital III and Health Innovations. To learn more about DEARhealth visit http://www.dearhealth.com or contact info@dearhealth.com.

Share article on social media or email:

GTMRx Executive Director Katherine H. Capps to Speak at APG Colloquium on Role of Pharmacists in Team-Based Care


News Image

Capps, who leads the GTMRx coalition of over 1,700 members calling for medication management reform, is part of the panel discussion on how pharmacists, as medication specialists, can work in collaborative practice with physicians to ensure the safe, effective, and appropriate use of medications.

Today, The Get the Medications Right™ (GTMRx) Institute, the catalyst for change to medication management that brings together critical stakeholders across health care, is announcing that Executive Director and Co-Founder, Katherine H. Capps will be speaking at this year’s America’s Physician Groups Colloquium (APG). The panel, comprised of leaders in healthcare and pharmacy practice, will address the importance of including pharmacists in the team-based care approach.

APG, which represents more than 335 physician groups with approximately 170,000 physicians providing care to nearly 90 million patients, is hosting this year’s Colloquium in Washington, D.C., and aims to provide hands-on knowledge and best practices from physician groups with successful track records in value-based care delivery, along with the big-picture view from policymakers bringing change to the healthcare system. Capps, who leads the GTMRx coalition of over 1,700 members calling for medication management reform, is part of the panel discussion on how pharmacists, as medication specialists, can work in collaborative practice with physicians to ensure the safe, effective, and appropriate use of medications. The goal of this approach is to decrease physician burnout, increase patient satisfaction, and save lives.

WHAT: APG Colloquium 2022 Breakout Session, “How Pharmacists Elevate Team-Based Care”

  • Attendees will hear about the novel ways some physician organizations are incorporating pharmacists on their teams to optimize medication use, improve patient care, reduce the total cost of care, and impact patient and provider satisfaction. Decreasing physician workload, increasing patient satisfaction, more effectively managing chronic conditions, decreasing hospitalizations, and reducing waste are driving value in these team-based care models.

WHO: Panelists include:

  • Katherine Herring Capps, Co-Founder & Executive Director, GTMRx Institute
  • Jordan Haag, PharmD, Director, Ambulatory Pharmacy Practice, Mayo Clinic
  • Bahar Davidoff, MBA, PharmD, Vice President, Pharmacy, Heritage Provider Network
  • Esteban Gallardo, PharmD, Chief of Pharmacy, CareAllies

WHEN: Tuesday, November 1 from 3:00 pm – 4:15 pm ET

WHERE: Grand Hyatt, Washington, DC

  • 1000 H St NW
  • Washington, DC 20001

The GTMRx Institute advocates for the broad adoption of CMM, a more rational process of care in which physicians and clinical pharmacists work together to ensure that each medication is appropriate for the patient; very much in line with the aims and goals of APG Colloquium 2022. For more information on the APG Colloquium 2022, and to register for the event, click here.

About the Get the Medications Right™ Institute

The GTMRx Institute is a catalyst for change that brings critical stakeholders together, bound by the urgent need to get the medications right. We are physicians, pharmacists, nurses, patients, health IT innovators, drug and diagnostics companies, consumer groups, employers, and payers—aligned to save lives and save money through comprehensive medication management. By showcasing evidence and innovation, we motivate practice transformation and push payment and policy reform. Together, we ACT to champion the appropriate, effective, safe, and precise use of medication and gene therapies. Learn more at gtmr.org.

Share article on social media or email:

New Jeeva eClinical Research Technology Enables Global Diversity Inclusion and Multi-Center Collaboration


News Image

Empowering remote patient-researcher interactions through the use of human-centric digital technology enables us to deliver dramatic improvements in the diversity of study populations scalable to a variety of clinical trials with rapid configurations rather than building a custom app each time.

Diversity and inclusion in clinical trials are critical to achieving accurate and reliable results.(1) Participation in clinical trials is voluntary, and individuals of different ages, genders, races, ethnicities, genetic backgrounds, geographic locations, and environments will respond differently to the same treatments. An effective way to achieve diversity in clinical trials is through decentralization with standardized procedures across multiple sites.(2) To facilitate the efficient execution of multi-center clinical trials globally, Dr. Harsha Rajasimha, Founder and CEO of Jeeva Informatics, and his team have developed the modular Jeeva™ eClinical Cloud.

Researchers in the U.S. and abroad have selected the Jeeva eClinical Platform for their pivotal clinical trials. U.S.-based Frantz Viral Therapeutics (FVT), a joint venture of Georgetown University Medical Center and Frantz Medical Group, developed and clinically demonstrated safety and efficacy in three applications of an antiviral drug for the treatment of HPV-associated pre-invasive disease of the anogenital tract. FVT selected the Jeeva eClinical platform to effectively execute a multi-site phase 2 clinical trial focused on the treatment of anal squamous intraepithelial lesions (anal HSIL). “I appreciate the functionality of the system. The Jeeva team has been helpful in working with us to provide exactly what we needed for our pivotal study,” says Mihaela Plesa, Director of Clinical Operations at Frantz Viral Therapeutics.

ImmunoACT is pioneering the first cell and gene therapy in India for patients’ long-term cures, both for common and rare diseases. They chose Jeeva to accelerate clinical development timelines without tapping into a large, full-service Contract Research Organization (CRO) or creating an in-house IT infrastructure. ImmunoACT selected Jeeva as a strategic technology partner to optimize their clinical trial operations from the very early stage through study closeout and long-term follow-up. “We need to bring the healthcare costs and product development costs down, especially in the developing world. Clinical trial costs are a significant part of product development costs. We are confident that by partnering with Jeeva, we can find the right value for money proposition without compromising on the quality,” says Shirish Arya, Director of Strategy at ImmunoACT.

With regional deployments of the Jeeva eClinical Cloud and TRIALMAGNET, we are able to support local regulatory requirements for the physical storage of clinical trial data and make it affordable in emerging markets with local partners and expertise on the ground.

The company has established numerous partnerships with CROs, site networks, and investigators in the US, India, and Latin America. Jeeva recently strategically partnered with MetFlux Research Services Pvt. Ltd. (MetFlux) for virtual clinical trials and software distribution in India. “Our partnership with Jeeva brings the world’s first-of-its-kind clinical research service, combining MetFlux’s Investigative PhysiologyTM platform with Jeeva’s eClinical trials platform. The partnership enables end-to-end pre-clinical and clinical trial solutions to pharma and healthcare companies seamlessly linking deep physiology research, advanced research analytics with the scalable digital clinical trial execution, and outstanding customer support,” says Professor Venkatesh Kareenhalli, Founder and Director of MetFlux.

U.S.-based Koncord Clinical Research Services (KCRS) needed a mobile-friendly software platform for engaging diverse patients in the Texas-Mexico border region. With Jeeva eClinical Cloud, the team is gathering accurate and faster eConsent, followed by biospecimen collection from elderly Hispanic persons with liver and gastrointestinal disorders. “In looking for a software partner, our research coordinators and investigators in the field could call the Jeeva team anytime, get reliable support, and have reassurance as we enroll patients on the go. You can count on Jeeva when time is of the essence in operationalizing a clinical trial,” attests Dr. Emmanuel Gorospe, Chief Medical Officer of KCRS.

Farmacon Global, a strategic CRO based in the U.S. with an extensive reach to clinical research sites in Latin America and outreach ability to Latinos in the U.S., recently partnered with Jeeva eClinical Platform to enable the Hispanic and Latinx communities with rare diseases, opportunities to access therapies in clinical trials. “Having evaluated numerous clinical trial platforms, Jeeva was refreshing in its vision to engage underrepresented minorities, focus on rare diseases, and collaborative approach beyond technology. We are eager to enable patient education, recruitment, and retention in rare disease clinical studies, such as patient registries and cell/gene therapies,” says Sara Tylosky, CEO of Farmacon Global.

Based on his lived experiences of caring for young loved ones with rare and chronic conditions, Dr. Rajasimha is driven to help patients gain access to critical and life-saving therapies faster and with the least burden. He says, “Empowering remote patient-researcher interactions through the use of human-centric digital technology enables us to deliver dramatic improvements in the diversity of study populations scalable to a variety of clinical trials with rapid configurations rather than building a custom app each time.”

The globalization, decentralization, and diversification of clinical trials are just beginning, but the future is bright.

About Jeeva Informatics Solutions

The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral training at NIH and FDA to accelerating therapies for rare and common conditions. He knew that technology in itself is not the limiting factor and that patient-centered design guided by stakeholder needs and regulatory requirements would guide their continuous learning digital platform. By digitizing and automating manual repetitive tasks and reducing the logistical burdens on patients and study teams by over 70%, Jeeva accelerates the process of bringing new medicines or vaccines to patients who need them by over 3x faster. The Virginia-based company’s modular software-as-a-service platform is fully scalable and facilitates patient enrollment, engagement, and evidence generation in clinical trials on any browser-enabled mobile device. Visit https://jeevatrials.com/

References: 

1. U.S. Department of Health and Human Services. “Diversity & Inclusion in Clinical Trials.” Updated February 7, 2022, National Institute on Minority Health and Healthy Disparities, nimhd.nih.gov/resources/understanding-health-disparities/diversity-and-inclusion-in-clinical-trials.html.

2. Homedes, Nuria; Ugalde, Antonio. “Globalization and Clinical Research in Latin America.” January 2014, Clinical Trials in Latin America: Where Ethics and Business Clash (pp.55-78), researchgate.net/publication/290735135GlobalizationandClinicalResearchinLatin_America.

Share article on social media or email:

Deploying a Patient-First Framework to Accelerate Recruitment & Reduce Overall Trial Timelines, Upcoming Webinar Hosted by Xtalks


Insider intelligence estimates that 70.6 million US patients, or 26.2% of the population, will use RPM tools by 2025.

The accelerated growth of patient-centric trials is driven by innovations in remote patient monitoring (RPM) and precision medicine. Insider intelligence estimates that 70.6 million US patients, or 26.2% of the population, will use RPM tools by 2025.

With this growth comes new potential, as sponsors and CROs gain the ability to drive better patient outcomes, increase patient adherence, improve health metrics, and ensure seamless patient onboarding.

However, it takes more than simply adding tools to your trial to gain this insight.

Join us on Thursday, November 10, 2022, as experts from Medable’s Digital Medicine and Partner Technologies area showcase: How digital data-flow designs, when mapped with clinical objectives, can support access to wider patient populations improving diversity & inclusion; How to increase operational efficiencies & enhance end-to-end patient enrollment, engagement, and retention; How first-hand experience in dermatology and oncology studies has identified robust patient populations which bring greater benefits to study outcomes; And how the financial value of implementing DCTs can be realized in your organization.

Join Gillian Livock, SVP & GM Digital Endpoints, Medable; Michael Howell, Ph.D., Chief Scientific Officer, DermTech; and Musaddiq (Muz) Khan, VP Therapeutic Area Solutions – Customer Value Team, Medable, for the live webinar on Thursday, November 10, 2022, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Deploying a Patient-First Framework to Accelerate Recruitment & Reduce Overall Trial Timelines.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: